Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gaspari

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Minerva Chirurgica|April 30, 1979
[Clinical study of a group of vagotomized patients]A Napolitano, A Gaspari, M Badiali
Journal of Drugs in Dermatology : JDD|March 22, 2005
Focus on: biologics that affect therapeutic agents in dermatologyYamini V Saripalli, Anthony A Gaspari
The British Journal of Dermatology|August 26, 2004
Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formationD L Cummins, A A Gaspari
Dermatologic Clinics|November 14, 2001
Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseasesJ R LaDuca, A A Gaspari
Current Protocols in Immunology|April 25, 2008
Contact hypersensitivityA A Gaspari, S I Katz
Archives of Dermatological Research|January 1, 1985
Lymphocyte transformation to membrane-conjugated, liposome-conjugated, or unconjugated pentadecylcatechol in the guinea pigA A Gaspari, R L Rietschel
Drugs & Aging|August 1, 1996
Drug treatment of skin and soft tissue infections in elderly long-term care residentsB H Lertzman, A A Gaspari
Current Directions in Autoimmunity|May 8, 2008
Allergic contact dermatitisMichael D Gober, Anthony A Gaspari
Journal of the American Academy of Dermatology|September 1, 1995
Cutaneous reactions to recombinant cytokine therapyL A Asnis, A A Gaspari
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|June 1, 1996
The use of transgenic mouse models to investigate the immune mechanisms of allergic contact dermatitis: an area of emerging opportunitiesR P Burns, A A Gaspari
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Minerva Chirurgica|April 30, 1979
[Clinical study of a group of vagotomized patients]A Napolitano, A Gaspari, M Badiali
Journal of Drugs in Dermatology : JDD|March 22, 2005
Focus on: biologics that affect therapeutic agents in dermatologyYamini V Saripalli, Anthony A Gaspari
The British Journal of Dermatology|August 26, 2004
Photoprotection by thalidomide in patients with chronic cutaneous and systemic lupus erythematosus: discordant effects on minimal erythema dose and sunburn cell formationD L Cummins, A A Gaspari
Dermatologic Clinics|November 14, 2001
Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseasesJ R LaDuca, A A Gaspari
Current Protocols in Immunology|April 25, 2008
Contact hypersensitivityA A Gaspari, S I Katz
Archives of Dermatological Research|January 1, 1985
Lymphocyte transformation to membrane-conjugated, liposome-conjugated, or unconjugated pentadecylcatechol in the guinea pigA A Gaspari, R L Rietschel
Drugs & Aging|August 1, 1996
Drug treatment of skin and soft tissue infections in elderly long-term care residentsB H Lertzman, A A Gaspari
Current Directions in Autoimmunity|May 8, 2008
Allergic contact dermatitisMichael D Gober, Anthony A Gaspari
Journal of the American Academy of Dermatology|September 1, 1995
Cutaneous reactions to recombinant cytokine therapyL A Asnis, A A Gaspari
American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|June 1, 1996
The use of transgenic mouse models to investigate the immune mechanisms of allergic contact dermatitis: an area of emerging opportunitiesR P Burns, A A Gaspari
Pageof 20